New triple inhaler shows promise for uncontrolled asthma

NCT ID NCT02676089

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new inhaler that combines three medicines (beclometasone, formoterol, and glycopyrronium) in people whose asthma was not well controlled with standard two-medication inhalers. Over 1,400 adults took part for 52 weeks. The triple inhaler improved lung function and reduced the number of moderate and severe asthma attacks compared to the two-medication inhaler alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Beclometasone, formoterol, and glycopyrronium (triple-combination inhaler)

What this could lead to

If successful, this triple therapy could offer better asthma control for people whose symptoms persist despite standard dual inhalers.

What could go wrong

This is a completed Phase 3 trial, but results may not apply to all asthma patients. The triple inhaler may cause side effects like dry mouth or throat irritation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chiesi Clinical Trial Site 100701

    Sofia, Bulgaria

  • Chiesi Clinical Trial Site 100702

    Pleven, Bulgaria

  • Chiesi Clinical Trial Site 100703

    Sofia, Bulgaria

  • Chiesi Clinical Trial Site 100704

    Sofia, Bulgaria

  • Chiesi Clinical Trial Site 100705

    Plovdiv, Bulgaria

  • Chiesi Clinical Trial Site 100706

    Stara Zagora, Bulgaria

  • Chiesi Clinical Trial Site 100707

    Blagoevgrad, Bulgaria

  • Chiesi Clinical Trial Site 100708

    Plovdiv, Bulgaria

  • Chiesi Clinical Trial Site 100709

    Sofia, Bulgaria

  • Chiesi Clinical Trial Site 100710

    Varna, Bulgaria

  • Chiesi Clinical Trial Site 100711

    Vidin, Bulgaria

  • Chiesi Clinical Trial Site 100712

    Stara Zagora, Bulgaria

  • Chiesi Clinical Trial Site 100713

    Haskovo, Bulgaria

  • Chiesi Clinical Trial Site 100715

    Plovdiv, Bulgaria

  • Chiesi Clinical Trial Site 100716

    Rousse, Bulgaria

  • Chiesi Clinical Trial Site 100718

    Gabrovo, Bulgaria

  • Chiesi Clinical Trial Site 100719

    Sofia, Bulgaria

  • Chiesi Clinical Trial Site 100720

    Burgas, Bulgaria

  • Chiesi Clinical Trial Site 100721

    Vidin, Bulgaria

  • Chiesi Clinical Trial Site 100722

    Montana, Bulgaria

  • Chiesi Clinical Trial Site 112701

    Minsk, Belarus

  • Chiesi Clinical Trial Site 112702

    Minsk, Belarus

  • Chiesi Clinical Trial Site 112703

    Homyel, Belarus

  • Chiesi Clinical Trial Site 112704

    Homyel, Belarus

  • Chiesi Clinical Trial Site 112705

    Minsk, Belarus

  • Chiesi Clinical Trial Site 203701

    Prague, Czechia

  • Chiesi Clinical Trial Site 203702

    Brandýs nad Labem, Czechia

  • Chiesi Clinical Trial Site 203703

    Prague, Czechia

  • Chiesi Clinical Trial Site 203704

    Opava, Czechia

  • Chiesi Clinical Trial Site 203705

    Kralupy nad Vltavou, Czechia

  • Chiesi Clinical Trial Site 203706

    Teplice, Czechia

  • Chiesi Clinical Trial Site 203707

    Jindřichův Hradec, Czechia

  • Chiesi Clinical Trial Site 203708

    Brno, Czechia

  • Chiesi Clinical Trial Site 203709

    Miroslav, Czechia

  • Chiesi Clinical Trial Site 203710

    Prague, Czechia

  • Chiesi Clinical Trial Site 203711

    Blansko, Czechia

  • Chiesi Clinical Trial Site 203712

    Varnsdorf, Czechia

  • Chiesi Clinical Trial Site 203713

    Rokycany, Czechia

  • Chiesi Clinical Trial Site 276701

    München, Germany

  • Chiesi Clinical Trial Site 276702

    Leipzig, Germany

  • Chiesi Clinical Trial Site 276703

    Hanover, Germany

  • Chiesi Clinical Trial Site 276704

    Leipzig, Germany

  • Chiesi Clinical Trial Site 276705

    Hamburg, Germany

  • Chiesi Clinical Trial Site 276707

    Frankfurt am Main, Germany

  • Chiesi Clinical Trial Site 276708

    Koblenz, Germany

  • Chiesi Clinical Trial Site 276709

    Berlin, Germany

  • Chiesi Clinical Trial Site 276710

    Leipzig, Germany

  • Chiesi Clinical Trial Site 276711

    Bonn, Germany

  • Chiesi Clinical Trial Site 276712

    Berlin, Germany

  • Chiesi Clinical Trial Site 276713

    Münster, Germany

  • Chiesi Clinical Trial Site 276714

    Frankfurt am Main, Germany

  • Chiesi Clinical Trial Site 276715

    Mainz, Germany

  • Chiesi Clinical Trial Site 276716

    Rosenheim, Germany

  • Chiesi Clinical Trial Site 348701

    Szeged, Hungary

  • Chiesi Clinical Trial Site 348702

    Siófok, Hungary

  • Chiesi Clinical Trial Site 348703

    Monor, Hungary

  • Chiesi Clinical Trial Site 348704

    Nyíregyháza, Hungary

  • Chiesi Clinical Trial Site 348705

    Szombathely, Hungary

  • Chiesi Clinical Trial Site 348706

    Szarvas, Hungary

  • Chiesi Clinical Trial Site 348707

    Balassagyarmat, Hungary

  • Chiesi Clinical Trial Site 348708

    Érd, Hungary

  • Chiesi Clinical Trial Site 348709

    Létavértes, Hungary

  • Chiesi Clinical Trial Site 348710

    Vásárosnamény, Hungary

  • Chiesi Clinical Trial Site 348712

    Gödöllő, Hungary

  • Chiesi Clinical Trial Site 348713

    Pécs, Hungary

  • Chiesi Clinical Trial Site 348714

    Nyíregyháza, Hungary

  • Chiesi Clinical Trial Site 348715

    Budapest, Hungary

  • Chiesi Clinical Trial Site 348717

    Komárom, Hungary

  • Chiesi Clinical Trial Site 348718

    Hatvan, Hungary

  • Chiesi Clinical Trial Site 348719

    Mórahalom, Hungary

  • Chiesi Clinical Trial Site 348720

    Pécs, Hungary

  • Chiesi Clinical Trial Site 348721

    Debrecen, Hungary

  • Chiesi Clinical Trial Site 380701

    Genova, Italy

  • Chiesi Clinical Trial Site 380702

    Pavia, Italy

  • Chiesi Clinical Trial Site 380703

    Catania, Italy

  • Chiesi Clinical Trial Site 380704

    Bologna, Italy

  • Chiesi Clinical Trial Site 380705

    Palermo, Italy

  • Chiesi Clinical Trial Site 380706

    Tradate, Italy

  • Chiesi Clinical Trial Site 432701

    Quilmes, Argentina

  • Chiesi Clinical Trial Site 432702

    Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 432703

    San Miguel de Tucumán, Argentina

  • Chiesi Clinical Trial Site 432704

    CABA, Argentina

  • Chiesi Clinical Trial Site 432705

    Mar del Plata, Argentina

  • Chiesi Clinical Trial Site 432706

    San Miguel de Tucumán, Argentina

  • Chiesi Clinical Trial Site 440701

    Šiauliai, Lithuania

  • Chiesi Clinical Trial Site 440702

    Vilnius, Lithuania

  • Chiesi Clinical Trial Site 440703

    Vilnius, Lithuania

  • Chiesi Clinical Trial Site 440705

    Vilnius, Lithuania

  • Chiesi Clinical Trial Site 616701

    Warsaw, Poland

  • Chiesi Clinical Trial Site 616702

    Bienkówka, Poland

  • Chiesi Clinical Trial Site 616703

    Pabianice, Poland

  • Chiesi Clinical Trial Site 616704

    Giżycko, Poland

  • Chiesi Clinical Trial Site 616705

    Wroclaw, Poland

  • Chiesi Clinical Trial Site 616707

    Lodz, Poland

  • Chiesi Clinical Trial Site 616708

    Lodz, Poland

  • Chiesi Clinical Trial Site 616709

    Poznan, Poland

  • Chiesi Clinical Trial Site 616710

    Tarnów, Poland

  • Chiesi Clinical Trial Site 616711

    Lodz, Poland

  • Chiesi Clinical Trial Site 616712

    Świdnik, Poland

  • Chiesi Clinical Trial Site 616713

    Bialystok, Poland

  • Chiesi Clinical Trial Site 616714

    Wroclaw, Poland

  • Chiesi Clinical Trial Site 616715

    Wroclaw, Poland

  • Chiesi Clinical Trial Site 616716

    Grudziądz, Poland

  • Chiesi Clinical Trial Site 616717

    Ostróda, Poland

  • Chiesi Clinical Trial Site 616718

    Bialystok, Poland

  • Chiesi Clinical Trial Site 616719

    Krakow, Poland

  • Chiesi Clinical Trial Site 616720

    Proszowice, Poland

  • Chiesi Clinical Trial Site 616721

    Skierniewice, Poland

  • Chiesi Clinical Trial Site 616722

    Bielsko-Biala, Poland

  • Chiesi Clinical Trial Site 616723

    Rzeszów, Poland

  • Chiesi Clinical Trial Site 616725

    Katowice, Poland

  • Chiesi Clinical Trial Site 616726

    Lodz, Poland

  • Chiesi Clinical Trial Site 616727

    Bydgoszcz, Poland

  • Chiesi Clinical Trial Site 616728

    Poznan, Poland

  • Chiesi Clinical Trial Site 616729

    Katowice, Poland

  • Chiesi Clinical Trial Site 616730

    Wilkowice, Poland

  • Chiesi Clinical Trial Site 616731

    Otwock, Poland

  • Chiesi Clinical Trial Site 616732

    Strzelce Opolskie, Poland

  • Chiesi Clinical Trial Site 616733

    Mrozy, Poland

  • Chiesi Clinical Trial Site 616734

    Krakow, Poland

  • Chiesi Clinical Trial Site 616735

    Rzeszów, Poland

  • Chiesi Clinical Trial Site 616736

    Krakow, Poland

  • Chiesi Clinical Trial Site 620702

    Lisbon, Portugal

  • Chiesi Clinical Trial Site 620703

    Figueira da Foz Municipality, Portugal

  • Chiesi Clinical Trial Site 620704

    Aveiro, Portugal

  • Chiesi Clinical Trial Site 620707

    Vila Nova de Gaia, Portugal

  • Chiesi Clinical Trial Site 620708

    Loures, Portugal

  • Chiesi Clinical Trial Site 642703

    Bucharest, Romania

  • Chiesi Clinical Trial Site 642704

    Iași, Romania

  • Chiesi Clinical Trial Site 642705

    Oradea, Romania

  • Chiesi Clinical Trial Site 642706

    Brasov, Romania

  • Chiesi Clinical Trial Site 642707

    Bucharest, Romania

  • Chiesi Clinical Trial Site 642708

    Bucharest, Romania

  • Chiesi Clinical Trial Site 642709

    Cluj-Napoca, Romania

  • Chiesi Clinical Trial Site 642710

    Iași, Romania

  • Chiesi Clinical Trial Site 642711

    Suceava, Romania

  • Chiesi Clinical Trial Site 642712

    Craiova, Romania

  • Chiesi Clinical Trial Site 642713

    Arad, Romania

  • Chiesi Clinical Trial Site 642714

    Cluj-Napoca, Romania

  • Chiesi Clinical Trial Site 642715

    Alexandru cel Bun, Romania

  • Chiesi Clinical Trial Site 642716

    Cluj-Napoca, Romania

  • Chiesi Clinical Trial Site 642717

    Bragadiru, Romania

  • Chiesi Clinical Trial Site 642718

    Cluj-Napoca, Romania

  • Chiesi Clinical Trial Site 642719

    Bucharest, Romania

  • Chiesi Clinical Trial Site 642721

    Timișoara, Romania

  • Chiesi Clinical Trial Site 642722

    Bacau, Romania

  • Chiesi Clinical Trial Site 642723

    Bucharest, Romania

  • Chiesi Clinical Trial Site 642726

    Cluj-Napoca, Romania

  • Chiesi Clinical Trial Site 643701

    Ryazan, Russia

  • Chiesi Clinical Trial Site 643702

    Moscow, Russia

  • Chiesi Clinical Trial Site 643703

    Saratov, Russia

  • Chiesi Clinical Trial Site 643704

    Kemerovo, Russia

  • Chiesi Clinical Trial Site 643705

    Moscow, Russia

  • Chiesi Clinical Trial Site 643706

    Moscow, Russia

  • Chiesi Clinical Trial Site 643707

    Nizhny Novgorod, Russia

  • Chiesi Clinical Trial Site 643708

    Vladikavkaz, Russia

  • Chiesi Clinical Trial Site 643709

    Tomsk, Russia

  • Chiesi Clinical Trial Site 643710

    Voronezh, Russia

  • Chiesi Clinical Trial Site 643711

    Pyatigorsk, Russia

  • Chiesi Clinical Trial Site 643712

    Saint Petersburg, Russia

  • Chiesi Clinical Trial Site 643713

    Kazan', Russia

  • Chiesi Clinical Trial Site 643714

    Saint Petersburg, Russia

  • Chiesi Clinical Trial Site 643715

    Saint Petersburg, Russia

  • Chiesi Clinical Trial Site 643716

    Saint Petersburg, Russia

  • Chiesi Clinical Trial Site 643717

    Novosibirsk, Russia

  • Chiesi Clinical Trial Site 643718

    Moscow, Russia

  • Chiesi Clinical Trial Site 643719

    Kazan', Russia

  • Chiesi Clinical Trial Site 643720

    Yaroslavl, Russia

  • Chiesi Clinical Trial Site 643721

    Yekaterinburg, Russia

  • Chiesi Clinical Trial Site 643722

    Moscow, Russia

  • Chiesi Clinical Trial Site 643723

    Nizhny Novgorod, Russia

  • Chiesi Clinical Trial Site 643724

    Odintsovo, Russia

  • Chiesi Clinical Trial Site 643725

    Saint Petersburg, Russia

  • Chiesi Clinical Trial Site 643726

    Smolensk, Russia

  • Chiesi Clinical Trial Site 643727

    Chelyabinsk, Russia

  • Chiesi Clinical Trial Site 643728

    Tomsk, Russia

  • Chiesi Clinical Trial Site 643729

    Orenburg, Russia

  • Chiesi Clinical Trial Site 643730

    Saint Petersburg, Russia

  • Chiesi Clinical Trial Site 643731

    Kemerovo, Russia

  • Chiesi Clinical Trial Site 643732

    Saint Petersburg, Russia

  • Chiesi Clinical Trial Site 643733

    Chelyabinsk, Russia

  • Chiesi Clinical Trial Site 643734

    Yaroslavl, Russia

  • Chiesi Clinical Trial Site 643735

    Moscow, Russia

  • Chiesi Clinical Trial Site 643736

    Saratov, Russia

  • Chiesi Clinical Trial Site 643737

    Saint Petersburg, Russia

  • Chiesi Clinical Trial Site 643738

    Vladimir, Russia

  • Chiesi Clinical Trial Site 643739

    Saint Petersburg, Russia

  • Chiesi Clinical Trial Site 643740

    Stavropol, Russia

  • Chiesi Clinical Trial Site 643741

    Kazan', Russia

  • Chiesi Clinical Trial Site 643742

    Yaroslavl, Russia

  • Chiesi Clinical Trial Site 643743

    Moscow, Russia

  • Chiesi Clinical Trial Site 643744

    Nizhny Novgorod, Russia

  • Chiesi Clinical Trial Site 643745

    Chelyabinsk, Russia

  • Chiesi Clinical Trial Site 643746

    Kazan', Russia

  • Chiesi Clinical Trial Site 643749

    Yaroslavl, Russia

  • Chiesi Clinical Trial Site 643752

    Saint Petersburg, Russia

  • Chiesi Clinical Trial Site 643754

    Izhevsk, Russia

  • Chiesi Clinical Trial Site 643755

    Ufa, Russia

  • Chiesi Clinical Trial Site 643757

    Saint Petersburg, Russia

  • Chiesi Clinical Trial Site 643758

    Saint Petersburg, Russia

  • Chiesi Clinical Trial Site 643759

    Tomsk, Russia

  • Chiesi Clinical Trial Site 703701

    Nové Zámky, Slovakia

  • Chiesi Clinical Trial Site 703702

    Ilava, Slovakia

  • Chiesi Clinical Trial Site 703703

    Spišská Nová Ves, Slovakia

  • Chiesi Clinical Trial Site 703704

    Bratislava, Slovakia

  • Chiesi Clinical Trial Site 703705

    Košice, Slovakia

  • Chiesi Clinical Trial Site 703706

    Košice, Slovakia

  • Chiesi Clinical Trial Site 703707

    Bratislava, Slovakia

  • Chiesi Clinical Trial Site 703708

    Štúrovo, Slovakia

  • Chiesi Clinical Trial Site 703709

    Prievidza, Slovakia

  • Chiesi Clinical Trial Site 724701

    Madrid, Spain

  • Chiesi Clinical Trial Site 724702

    A Coruña, Spain

  • Chiesi Clinical Trial Site 724703

    Badajoz, Spain

  • Chiesi Clinical Trial Site 724704

    Madrid, Spain

  • Chiesi Clinical Trial Site 724705

    Málaga, Spain

  • Chiesi Clinical Trial Site 724706

    Badalona, Spain

  • Chiesi Clinical Trial Site 724707

    Sabadell, Spain

  • Chiesi Clinical Trial Site 792701

    Ankara, Turkey (Türkiye)

  • Chiesi Clinical Trial Site 792702

    Ankara, Turkey (Türkiye)

  • Chiesi Clinical Trial Site 792703

    Antalya, Turkey (Türkiye)

  • Chiesi Clinical Trial Site 792705

    Maltepe, Turkey (Türkiye)

  • Chiesi Clinical Trial Site 792706

    Kocaeli, Turkey (Türkiye)

  • Chiesi Clinical Trial Site 792707

    Istanbul, Turkey (Türkiye)

  • Chiesi Clinical Trial Site 792708

    Mersin, Turkey (Türkiye)

  • Chiesi Clinical Trial Site 792709

    Yenişehir, Turkey (Türkiye)

  • Chiesi Clinical Trial Site 792710

    Aydin, Turkey (Türkiye)

  • Chiesi Clinical Trial Site 804701

    Dnipro, Ukraine

  • Chiesi Clinical Trial Site 804703

    Vinnytsia, Ukraine

  • Chiesi Clinical Trial Site 804704

    Zaporizhzhya, Ukraine

  • Chiesi Clinical Trial Site 804705

    Kyiv, Ukraine

  • Chiesi Clinical Trial Site 804706

    Vinnytsia, Ukraine

  • Chiesi Clinical Trial Site 804707

    Vinnytsia, Ukraine

  • Chiesi Clinical Trial Site 804708

    Zhytomyr, Ukraine

  • Chiesi Clinical Trial Site 804709

    Kharkiv, Ukraine

  • Chiesi Clinical Trial Site 804710

    Kherson, Ukraine

  • Chiesi Clinical Trial Site 804711

    Ivano-Frankivsk, Ukraine

  • Chiesi Clinical Trial Site 804712

    Lviv, Ukraine

  • Chiesi Clinical Trial Site 804713

    Kiev, Ukraine

  • Chiesi Clinical Trial Site 804714

    Vinnytsia, Ukraine

  • Chiesi Clinical Trial Site 804715

    Sumy, Ukraine

  • Chiesi Clinical Trial Site 826701

    Soham, United Kingdom

  • Chiesi Clinical Trial Site 826702

    Llanelli, United Kingdom

  • Chiesi Clinical Trial Site 826703

    London, United Kingdom

  • Chiesi Clinical Trial Site 826704

    Manchester, United Kingdom